Improved Medication Adherence with the Use of Extended-Release Tacrolimus in Liver Transplant Recipients: A Pilot Randomized Controlled Trial
Background. Nonadherence to immunosuppression in liver transplant recipients (LTRs) leads to deterioration in health outcomes. Once-dailyextended-release tacrolimus (TAC-ER) may improve adherence when compared to twice-dailyimmediate-release tacrolimus (TAC-IR). Methods. We conducted a randomized co...
Saved in:
Main Authors: | Manisha Verma, Radi Zaki, Johnathan Sadeh, John P. Knorr, Mark Gallagher, Afshin Parsikia, Victor Navarro |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Journal of Transplantation |
Online Access: | http://dx.doi.org/10.1155/2023/7915781 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The association between serum tacrolimus concentrations and BK viruria in kidney transplant recipients
by: Napatsorn Kraivisitkul, et al.
Published: (2025-01-01) -
Tacrolimus Toxicity due to Biliary Obstruction in a Combined Kidney and Liver Transplant Recipient
by: Samuel Chan, et al.
Published: (2017-01-01) -
Switching Stable Kidney Transplant Recipients to a Generic Tacrolimus Is Feasible and Safe, but It Must Be Monitored
by: Fernando González, et al.
Published: (2017-01-01) -
Tacrolimus toxicity management in a pregnant kidney transplant recipient with newly diagnosed human immunodeficiency virus: A case report
by: Ahmad Matarneh, et al.
Published: (2025-02-01) -
Time in therapeutic range of tacrolimus in allogeneic hematopoietic stem cell transplant recipients is associated with acute graft-versus-host disease prophylaxis
by: Naoki Yoshikawa, et al.
Published: (2025-01-01)